Fuelling Innovation through Strategic Funding

Applicant Eligibility

1. The Lead Investigator and Co-Investigators as defined in Grant Terms and Conditions should:
   • Hold a primary appointment in a Singapore publicly funded research institution or an institute of higher learning (IHL). The Lead Investigator must hold a primary appointment of at least 0.7 FTE in Singapore.
   • Lead a laboratory or research programme which carries out research in Singapore.
   • Possess track record of leadership ability in coordinating research programmes and providing mentorship to research teams as well as having productive research outcomes. A track record in securing IRS will be advantageous.
2. Exceptions to the above eligibility criteria will be considered on a case-by-case basis. Please submit a request to the NATi Coordinating Office.
3. Collaborators as defined in Grant Terms and Conditions are not eligible to receive NATi funding. Companies can participate in NATi projects only as collaborators. There are no exceptions.

Scope

Strategic research projects with industry that can help to accelerate the development and commercialisation of RNA drugs and RNA therapeutics-related technologies in Singapore

Key Requirements

1. A Research Collaboration Agreement (RCA) with an industry partner should be in its final stages of negotiation and/or execution, pending NATi’s funding
2. Cash contributions from industry partner is required, and should match at least 50% of the total grant request. In-kind contributions will be taken into consideration during evaluation.